Expansion of the CACHE Governing Board
We are proud to announce the expansion of the CACHE Governing Board, which now includes representatives from four pharmaceutical companies; UCB, AstraZeneca, Bayer, and Boehringer Ingelheim. The Governing Board’s role is to actively lead and provide direction for the CACHE challenges, as well as nominate members for its independent expert panels for target selection, application […]
DMOS program funds three projects working towards treatments for rare diseases
We are proud to announce the first three recipients of funding via our Developing Medicines through Open Science program. These grantees are working towards treatments and cures for three rare diseases: a genetic neuromuscular disorder, a pediatric brain cancer, and a liver disease. Access this press release on Business Wire For more information, contact:Estrid Jakobsen […]
